Omega Diagnostics Group PLC Exercise of Options and Total Voting Rights (9605Q)
02 November 2021 - 2:28AM
UK Regulatory
TIDMODX
RNS Number : 9605Q
Omega Diagnostics Group PLC
01 November 2021
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Exercise of Options and Total Voting Rights
Omega (AIM: ODX), the medical diagnostics company focused on
Global Health (CD4 and COVID-19) and Health and Nutrition,
announces that it has agreed to allot in total 25,000 new ordinary
shares of 4 pence each in the capital of the Company ("Ordinary
Shares") following the exercise of share options under the 2007 EMI
Share Option Scheme by certain option holders.
Application has been made to the London Stock Exchange for the
25,000 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 9 November
2021.
After Admission, the total number of Ordinary Shares in issue
will be 182,682,404 and the total number of voting rights will
therefore be 182,682,404. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
Contacts:
Omega Diagnostics Group PLC www.omegadiagnostics.com
Colin King, Chief Executive via Walbrook PR
Chris Lea, CFO
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Edward Whiley (Corporate
Finance)
Alice Lane/Charlotte Sutcliffe
(ECM)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRFSLFIFEFSEEF
(END) Dow Jones Newswires
November 01, 2021 11:28 ET (15:28 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2023 to Apr 2024